[Guidelines for treating HIV-infected adults and post-exposure prophylaxis for HIV infection].

Q3 Medicine
Svatava Snopková, Hanuš Rozsypal, Viktor Aster, Dalibor Sedláček, Pavel Dlouhý, Jaroslav Kapla, David Jilich, Dan Veselý, Zdeňka Jerhotová, Lenka Olbrechtová, Alena Zjevíková, Milan Zlámal
{"title":"[Guidelines for treating HIV-infected adults and post-exposure prophylaxis for HIV infection].","authors":"Svatava Snopková,&nbsp;Hanuš Rozsypal,&nbsp;Viktor Aster,&nbsp;Dalibor Sedláček,&nbsp;Pavel Dlouhý,&nbsp;Jaroslav Kapla,&nbsp;David Jilich,&nbsp;Dan Veselý,&nbsp;Zdeňka Jerhotová,&nbsp;Lenka Olbrechtová,&nbsp;Alena Zjevíková,&nbsp;Milan Zlámal","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Antiretroviral therapy represents an essential element in the approach to treatment and prevention of human immunodeficiency virus (HIV). It has changed the fatal disease to a manageable chronic condition and is the most effective prevention of its human-to-human transmission. Knowledge regarding biological characteristics of the virus, its behavior in a human host and our understanding of these phenomena have been extended by clinical experience, new clinical data and recent scientific progress. The development of new drugs becomes a modifier for the existing therapeutic strategy and preference. Certain points are more specific than in the previous guidelines. Definitions of certain clinical and laboratory conditions have been specified more accurately. The indications of specific antiretroviral agents and pitfalls of their use in lifelong antiretroviral treatment are also described more in detail. The document is a result of a general consensus among infectious disease specialists working with HIV patients in the Czech Republic. It should serve as a basic instrument for clinicians recommending treatment of HIV infection as well as a foundation for the society when dealing with both state authorities and health care payers.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"25 3","pages":"97-120"},"PeriodicalIF":0.0000,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinicka mikrobiologie a infekcni lekarstvi","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Antiretroviral therapy represents an essential element in the approach to treatment and prevention of human immunodeficiency virus (HIV). It has changed the fatal disease to a manageable chronic condition and is the most effective prevention of its human-to-human transmission. Knowledge regarding biological characteristics of the virus, its behavior in a human host and our understanding of these phenomena have been extended by clinical experience, new clinical data and recent scientific progress. The development of new drugs becomes a modifier for the existing therapeutic strategy and preference. Certain points are more specific than in the previous guidelines. Definitions of certain clinical and laboratory conditions have been specified more accurately. The indications of specific antiretroviral agents and pitfalls of their use in lifelong antiretroviral treatment are also described more in detail. The document is a result of a general consensus among infectious disease specialists working with HIV patients in the Czech Republic. It should serve as a basic instrument for clinicians recommending treatment of HIV infection as well as a foundation for the society when dealing with both state authorities and health care payers.

[成人艾滋病毒感染者治疗和接触后艾滋病毒感染预防指南]。
抗逆转录病毒疗法是治疗和预防人体免疫缺陷病毒(艾滋病毒)方法中的一个基本要素。它已将这种致命疾病转变为可控制的慢性疾病,并且是最有效的人际传播预防措施。由于临床经验、新的临床数据和最近的科学进展,有关该病毒的生物学特性、其在人类宿主中的行为以及我们对这些现象的理解得到了扩展。新药的开发成为现有治疗策略和偏好的调节剂。某些要点比以前的指导方针更具体。某些临床和实验室条件的定义已被更准确地指定。具体的抗逆转录病毒药物的适应症和陷阱,他们在终身抗逆转录病毒治疗中使用也更详细地描述。该文件是捷克共和国与艾滋病毒患者一起工作的传染病专家达成普遍共识的结果。它应作为临床医生推荐艾滋病毒感染治疗的基本工具,以及社会在与国家当局和保健支付者打交道时的基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Klinicka mikrobiologie a infekcni lekarstvi
Klinicka mikrobiologie a infekcni lekarstvi Medicine-Infectious Diseases
CiteScore
0.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信